Oral Progesterone and Estrogen/Progestogen Therapy: Effects of natural and synthetic hormones on subfractions of HDL cholesterol and liver proteins

References

• Elkik F, Compel A, Mercier-Bodard C, et al. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in post-menopausal women. Am J Obstet Gynecol 1982; 143: 888–92
   PubMed Web of Science ®Google Scholar
• Holst J. Percutaneous estrogen therapy. Endometrial response and metabolic effects. Acta Obstet Gynecol Scand Suppl 1983; 115
   Google Scholar
• Lyrenäs S, Carlström K, Bäckström T, von Shoultz B. A comparison of oestrogen levels after percutaneous and oral administration of oestradiol-17β. Br J Obstet Gynaecol 1981; 88: 181–7
   PubMedGoogle Scholar
• Fåhraeus L, Wallentin L. High density lipoprotein subfractions during oral and cutaneous administration of 17β-estradiol to menopausal women. J Clin Endocrinol Metab 1983; 56: 797–801
   PubMed Web of Science ®Google Scholar
• Aylward M, Maddock J, Rees P L. Natural estrogen replacement therapy and blood clotting. Br Med J 1976; i: 220
   Google Scholar
• Bolton C H. The effect of ethinyl oestradiol and conjugated oestrogens on plasma lipids in oophorectomised women. The Management of the Menopause and Postmenopausal Years, S Campbell. MTP Press, Lancaster 1976; 185–94
   Google Scholar
• Åstedt B. Coagulation and fibrinolytic studies on 17-β-estradiol and synthetic estrogens. Acta Obstet Gynecol Scand 1977, Suppl 65: 45–48
   Google Scholar
• Helgason S. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Acta Obstet Gynecol Scand Suppl 1982; 107
   Google Scholar
• Mandel F P., Geola F L., Lu J KH, et al. Biologic effects of various doses of ethinyl estradiol in postmenopausal women. Obstet Gynecol 1982; 59: 673–79
   PubMed Web of Science ®Google Scholar
• King R BJ, Townsend P T., Whitehead M I. The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins. J Ster Biochem 1981; 14: 235–38
   Google Scholar
• Pasetto N, Piccione E, Pasetto F, Baschieri L, Maturi R. Treatment of patients at risk. Cross-over study between natural estrogens. The Menopause and the Postmenopause, N Pasetto, R Paoletti, J L. Ambrus. MTP Press, Lancaster 1980; 141–51
   Google Scholar
• Judd H L., Cleary R E., Creasman W T., et al. Estrogen replacement therapy. Obstet Gynecol 1981; 58: 267–75
   PubMed Web of Science ®Google Scholar
• Vaughn T C., Hammond C B. Estrogen replacement therapy. Clin Obstet Gynecol 1981; 24: 253–83
   PubMedGoogle Scholar
• Wallentin L, Larsson-Cohn U. Metabolic and hormonal effects of postmenopausal oestrogen replacement. II. Plasma lipids. Acta Endocrinol (Copenh) 1977; 86: 597–607
   PubMedGoogle Scholar
• Silfverstolpe G, Gustafson A, Samsioe G, Svanborg A. Lipid metabolic studies in oophorectomized women: Effects induced by two different estrogens on serum lipids and lipoproteins. Gynecol Obstet Invest 1980; 11: 161–9
   PubMedGoogle Scholar
• Hammond C B., Maxson W S. Current status of estrogen therapy for the menopause. Fertil Steril 1982; 37: 5–25
   PubMed Web of Science ®Google Scholar
• Clark J H., Paszko Z, Peck E J., Jr. Nuclear binding of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. Endocrinology 1977; 100: 91–6
   PubMed Web of Science ®Google Scholar
• Bergink E W. Oestriol receptor interactions: their biological importance and therapeutic implications. Acta Endocrinol (Copenh) 1980; 94(suppl 233)9–16
   Google Scholar
• Englund D E., Johansson E DB. Endometrial effects of oral estriol treatment in postmenopausal women. Acta Obstet Gynecol Scand 1980; 59: 449–51
   PubMed Web of Science ®Google Scholar
• Jordan V C. The pharmacology of tamoxifen with special reference to the control of hormone-dependent cancer. Antihormones, M K. Agarwal. Elsevier/North-Holland Biomedical Press, Amsterdam 1979; 235–52
   Google Scholar
• Helgason S, Wilking N, Carlström K, Damber M G., von Schoultz B. A comparative study on the estrogenic effects of tamoxifen and 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab 1982; 54: 404–8
   PubMed Web of Science ®Google Scholar
• Swenerton K D., Shaw D, Shite G W., Boyes D A. Treatment of advanced endometrial carcinoma with tamoxifen. N Engl J Med 1979; 301: 105
   Google Scholar
• Sekiya S, Takamizawa H. Non-steroidal anti-estrogens and hormone-responsive carcinomas. Antihormones, M K. Agarwal. Elsevier/North-Holland Biomedical Press, Amsterdam 1979; 269–81
   Google Scholar
• Edgren R A., Sturtevant F M. Potencies of oral contraceptives. Am J Obstet Gynecol 1976; 125: 1029–38
   PubMedGoogle Scholar
• Mauvais-Jarvis P. Contraception orale: Incertitudes et perspectives. Rev Prat 1978; 28: 3143–56
   Google Scholar
• Briggs M. Minireview: The beagle dog and contraceptive steroids. Life Sci 1977; 21: 275–84
   PubMed Web of Science ®Google Scholar
• Mishell D R. Progestins in contraception—present and future. Progesterone and Progestins, C W. Bardin, E Milgröm, P. Mauvais-Jarvis. Raven Press, New York 1983; 383–94
   Google Scholar
• Pannuti F, DiMarco A R., Martoni A, . Medroxyprogesterone acetate in the treatment of metastatic breast cancer. Seven years of experience. Role of Medroxyprogesterone in Endocrine-Related Tumors, S Iacobelli, A. DiMarco, et al. Raven Press, New York 1980; 72–92
   Google Scholar
• Taylor R W. The treatment of endometrial carcinoma with medroxyprogesterone acetate. Role of Medroxyprogesterone in Endocrine-Related Tumors, Volume 11, L Campio, Robustelli Della, G Cuna, R W. Taylor. Raven Press, New York 1983; 157–62
   Google Scholar
• Edgren R A., Jones R EC, Peterson D L. A biological classification of progestational agents. Fertil Steril 1967; 18: 238–56
   PubMed Web of Science ®Google Scholar
• Lane G, Siddle N C., Ryder T A., Pryse-Davies J, King R JB, Whitehead M I. Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium. Br Med J 1983; 287: 1241–5
   PubMed Web of Science ®Google Scholar
• Bar din C W., Milgröm E, Mauvais-Jarvis P, Comps. Progesterone and Progestins. 1st ed. Raven Press, New York 1983
   Google Scholar
• Winkel C A., Casey M L., Simpson E R., MacDonald P C. Deoxycorticosterone biosynthesis from progesterone in kidney tissue of the human fetus. J Clin Endocrinol Metab 1981; 53: 10–5
   PubMed Web of Science ®Google Scholar
• Casey M L., MacDonald P C. Formation of deoxycorticosterone from progesterone in extra-adrenal tissues: Demonstration of steroid 21-hydroxylase activity in human aorta. J Clin Endocrinol Metab 1982; 55: 804–6
   Google Scholar
• Jenkins N, Fotherby K. Binding of the contraceptive steroids norgestrel and norethisterone in human plasma. J Steroid Biochem 1980; 11: 521–7
   Google Scholar
• Nilsson B, Södergård R, Damber M G., von Shoultz B. Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity. Fertil Steril 1982; 38: 48–53
   PubMed Web of Science ®Google Scholar
• Russ E M., Eder H A., Barr D P. Influence of gonadal hormones on protein-lipid relationships in human plasma. Am J Med 1955; 19: 4–24
   PubMed Web of Science ®Google Scholar
• Meldrum D R., Pardridge W M., Karow W G., Rivier J, Vale W, Judd H L. Hormonal effects of danazol and medical oophorectomy in endometriosis. Obstet Gynecol 1983; 62: 480–5
   Google Scholar
• Nilsson B, Södergård R, Damber M G., Damber J E., von Schoultz B. Free testosterone levels during danazol therapy. Fertil Steril 1983; 39: 505–9
   PubMed Web of Science ®Google Scholar
• Carter J. The effect of progesterone, oestradiol and HCG on cell-mediated immunity in pregnant mice. J Reprod Fert 1976; 46: 211–6
   Google Scholar
• Siteri P K., Febres F, Clemens L E., Chang R J., Condos B, Stites D. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant?. Ann NY Acad Sci 1977; 286: 384–97
   Google Scholar
• Briggs M H., Briggs M. Glucocorticoid properties of progestogens. Steroids 1973; 22: 555–9
   PubMed Web of Science ®Google Scholar
• Jones J R., Del Rosario L, Soriero A A. Adrenal function in patients receiving medroxyprogesterone acetate. Contraception 1974; 10: 1–12
   Google Scholar
• Cortes Funes H, Madrigal P L., Perez Mangas G, Mendiola C. Medroxyprogesterone acetate at two different high doses for the treatment of advanced breast cancer. Role of Medroxyprogesterone in Endocrine-Related Tumors, Volume 11, L Campio, Robustelli Della, G Cuna, R W. Taylor. Raven Press, New York 1983; 77–83
   Google Scholar
• Goldzieher J W., Chenault C B., de la Pena A, Dozier T S., Kraemer D C. Comparative studies of the ethinyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons and beagles. Fertil Steril 1978; 30: 522–33
   PubMed Web of Science ®Google Scholar
• Larsson-Cohn U, Wallentin L, Zador G. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Horm Metab Res 1979; 437–40
   Google Scholar
• Knopp R H., Walden C E., Wahl P W., et al. Oral contraceptive and postmenopausal estrogen effects on lipo-protein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. J Clin Endocrinol Metab 1981; 53: 1123–32
   PubMed Web of Science ®Google Scholar
• Morrisett J D., Jackson R L., Gotto A M. Lipid-protein interactions in the plasma lipoproteins. Biochim Bio-phys Acta 1977; 472: 93–133
   PubMed Web of Science ®Google Scholar
• Alaupovic P, Lee D M., McConathy W J. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta 1972; 260: 689–707
   PubMed Web of Science ®Google Scholar
• Schaefer E J., Eisenberg S, Levy R I. Lipoprotein apoprotein metabolism. J Lipid Res 1978; 19: 667–87
   PubMed Web of Science ®Google Scholar
• Sigurdsson G, Noel S P., Havel R J. Quantification of the hepatic contribution to the catabolism of high density lipoprotein in rats. J Lipid Res 1979; 20: 316–24
   PubMedGoogle Scholar
• Miller N E., Hammet F, Saltissi S, et al. Relation of an-giographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J 1981; 282: 1741–4
   PubMed Web of Science ®Google Scholar
• Felker T F., Fainson M, Hamilton R L., Havel R J. Secretion of the arginine rich and A-I apolipoproteins by the isolated perfused rat liver. J Lipid Res 1977; 18: 465–73
   PubMed Web of Science ®Google Scholar
• Glickman R M., Green P HR, Lees R S., Tall A R. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. N Engl J Med 1978; 299: 1424–7
   Google Scholar
• Tall A R., Small D M. Plasma high-density lipoproteins. N Engl J Med 1978; 299: 1232–6
   PubMed Web of Science ®Google Scholar
• Nestel P J., Fidge N H. The physiology of plasma lipoproteins. Lipoproteins, atherosclerosis and coronary heart disease, N E. Miller, B. Lewis. Elsevier/North-Holland Biomedical Press, Amsterdam 1981; 3–29
   Google Scholar
• Taskinen M R., Nikkilä E A. High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man—evidence for reciprocal regulation of HDL, and HDL, levels by lipoprotein lipase. Clin Chim Acta 1981; 112: 325–32
   PubMed Web of Science ®Google Scholar
• Nikkilä E A., Kuusi T, Harno K, Tikkanen M, Taskinen M R. Lipoprotein lipase and hepatic endothelial lipase are key enzymes in the metabolism of plasma high density lipoproteins, particularly of HDL2. Atherosclerosis V, A M. Gotto, Jr., L C. Smith, B. Allen. Springer Verlag, New York 1980; 387–92
   Google Scholar
• Miller N E., Nestel P J., Clifton-Bligh P. Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in men. Atherosclerosis 1976; 23: 535–47
   PubMed Web of Science ®Google Scholar
• Jones H B., Gofman J W., Lindgren F T., et al. Lipoproteins in atherosclerosis. Am J Med 1951; 11: 358–80
   PubMed Web of Science ®Google Scholar
• Lewis B, Chait A, Oakley C MO, et al. Serum lipoprotein abnormalities in patients with ischemic heart disease: Comparison with a control population. Br Med J 1974; 3: 489–93
   PubMedGoogle Scholar
• Miller G J. High density lipoproteins and atherosclerosis. Ann Rev Med 1980; 31: 97–108
   PubMed Web of Science ®Google Scholar
• The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. Lipid Research Clinics Program. JAMA 1984; 251: 351–64
   PubMed Web of Science ®Google Scholar
• Barr D P., Russ E M., Eder H A. Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am J Med 1951; 11: 480–93
   PubMed Web of Science ®Google Scholar
• Castelli W P., Doyle J T., Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease. The Cooperative Lipoprotein Phenotyping Study. Circulation 1977; 55: 767–72
   PubMed Web of Science ®Google Scholar
• Rhoads G G., Gulbrandsen C L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med 1976; 294: 293–8
   PubMed Web of Science ®Google Scholar
• Gordon T, Castelli W P., Hjortland M C., Kannel W B., Dawber T R. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977; 62: 707–14
   PubMed Web of Science ®Google Scholar
• Miller N E., Thelle D S., Förde O H., Mjös O D. The Tromsø heart study. High density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1977; ii: 965–69
   Google Scholar
• Tyroler H S. Epidemiology of plasma high-density lipoprotein cholesterol levels. Circulation Suppl IV 1980, comp.
   Google Scholar
• Gofman J W., Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation 1966; 34: 679–97
   PubMed Web of Science ®Google Scholar
• Fager G, Wiklund O, Olofsson S O., Wilhelmsson C, Bondjers G. Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors. Atherosclerosis 1980; 36: 67–74
   Google Scholar
• Avogaro P, Cazzaloto G, Bittolo Bon O., Quinci G B. Are apolipoproteins better discriminators than lipids for atherosclerosis?. Lancet 1979; i: 901–3
   Google Scholar
• Carew T E., Koschinsky T, Hayes S B., Steinberg D. A mechanism by which high density lipoproteins may slow the atherogenic process. Lancet 1976; i: 1315–7
   Google Scholar
• Stein O, Stein Y. High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture. Biochim Biophys Acta 1976; 431: 363–8
   PubMedGoogle Scholar
• World Health Statistics Annual. Vital statistics and causes of death 1980. WHO, Geneva 1980
   Google Scholar
• Heiss G, Tamir I, Davis C E., et al. Lipoprotein cholesterol distributions in selected North American populations: The lipid research clinics program prevalence study. Circulation 1980; 61: 302–15
   PubMed Web of Science ®Google Scholar
• Barclay M, Barclay R K., Skipski V P. High-density lipoprotein concentrations in men and women. Nature 1963; 200: 362–3
   PubMed Web of Science ®Google Scholar
• Ross R K., Paganini-Hill A, Mack T M., Arthur M, Henderson B E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981; i: 858–60
   Google Scholar
• Bain C, Willet W, Hennekens C H., et al. Use of post-menopausal hormones and risk of myocardial infarction. Circulation 1981; 64: 42–46
   PubMed Web of Science ®Google Scholar
• Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560–3
   PubMed Web of Science ®Google Scholar
• Mattsson L, Cullberg G, Samsioe G. Influence of esterified estrogens and medroxyprogesterone on lipid metabolism and sex steroids. A study in oophorectomised women. Horm Metab Res 1982; 14: 602–6
   Google Scholar
• Silfverstolpe G, Gustafson A, Samsioe G, Svanborg A. Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens. Maturitas 1982; 4: 103–11
   Google Scholar
• Kauppila A, Jäne O, Kivinen S, et al. Postmenopausal hormone replacement therapy with estrogen periodically supplemented with antiestrogen. Am J Obstet Gynecol 1981; 140: 787–92
   Google Scholar
• Geola F L., Frumar A M., Tataryn A M., et al. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1980; 620–5
   Google Scholar
• Damber M G., Sandström B, von Schoultz B, Stigbrand T. A new and sensitive method for quantifying and comparing the biological potency of various estrogens in man. Acta Obstet Gynecol Scand 1979; 58: 527–30
   PubMed Web of Science ®Google Scholar
• El Makhzangy M N., Wynn V, Lawrence D M. Sex hormone binding globulin capacity as an index of oestrogenicity and androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39–45
   PubMedGoogle Scholar
• Stein O, Stein Y. Lecithin synthesis, intracellular transport, and secretion in rat liver. IV. Radioautographic and biochemical study of choline-deficient rats injected with choline-3H. J Cell Biol 1969; 40: 461–83
   Google Scholar
• Alling C, Cahlin E, Scherstén T. Relationship between fatty acid patterns of serum, hepatic and biliary lecithins in man. Effects of sucrose feeding. Biochim Biophys Acta 1973; 296: 518–26
   PubMedGoogle Scholar
• Gompertz D. Phospholipids and their metabolism. J Clin Pathol 1973; 26(suppl)11–6
   Google Scholar
• Bjørnstad P, Bremer J. In vivo studies on pathways for the biosynthesis of lecithin in the rat. J Lipid Res 1966; 7: 38–45
   PubMed Web of Science ®Google Scholar
• Lyman R L., Hopkins S M., Sheehan G, Tinoco J. Effects of estradiol and testosterone on the incorporation and distribution of (Me14C) Methionine methyl in rat liver lecithins. Biochim Biophys Acta 1968; 152: 197–207
   PubMedGoogle Scholar
• Trewhella M A., Collins F D. Pathways of phosphatidylcholine biosynthesis in rat liver. Biochim Biophys Acta 1973; 296: 51–61
   PubMed Web of Science ®Google Scholar
• Lagrelius A, Johnson P, Lunell N O., Samsioe G. Treatment with oral estrone sulphate in the female climacteric. I. Influence on lipids. Acta Obstet Gynecol Scand 1981; 60: 27–31
   Web of Science ®Google Scholar
• Silfverstolpe G, Johnson P, Samsioe G, Svanborg A, Gustafson A. Effects induced by two different estrogens on serum individual phospholipids and serum lecithin fatty acid composition. Horm Metab Res 1981; 13: 141–45
   Google Scholar
• Rosing U, Johnson P, Ölund A, Samsioe G. Relative fatty acid composition of serum lecithin in the second half of the normal pregnancy. Gynecol Obstet Invest 1982; 14: 225–35
   Google Scholar
• Feldman H, Rodbard D. Mathematical aspects on radioimmunoassay. Principles of Competitive Protein Binding, W D. Odell, W H. Daughaday. Lippincott, Philadelphia and Toronto 1970; 158–73
   Google Scholar
• Brody S, Carlström K, Lagrelius A, Lunell N-O, Rosenborg L. Serum levels of 4-androstene-3,17-dione in menstruating and postmenopausal women. Evaluation of a radioimmunoassay and correlation with bone mineral content and endometrial pathology. Acta Obstet Gynecol Scand 1983; 62: 531–534
   PubMed Web of Science ®Google Scholar
• Manlimos F S., Maroulis G B., Abraham G E. Radioimmunoassay of plasma 11-deoxycorticosterone. Anal Lett 1975; 8: 931–8
   Web of Science ®Google Scholar
• Helgason S, Carlström K, Damber M G., von Schoultz B. Gonadotropins and prolactin during estrogen replacement therapy. Acta Obstet Gynecol Scand 1981; 60: 515–6
   Web of Science ®Google Scholar
• Shanbhag V P., Södergård R, Carstensen H, Albertsson PÅ. A new method for the determination of the binding capacity of testosterone-estradiol-binding globulin in human plasma. J Steroid Biochim 1973; 4: 537–50
   PubMedGoogle Scholar
• Rodkey F L. Direct spectrophotometric determination of albumin in human serum. Clin Chim Acta 1965; 11: 478–87
   Google Scholar
• Damber M G., von Schoultz B, Stigbrand T, Carlström K. A radioimmunoassay for the pregnancy zone protein. Clin Chim Acta 1976; 66: 85–8
   PubMedGoogle Scholar
• Gidez L I., Miller G J., Burstein M, Eder H A. Analyses of plasma high density lipoprotein subclasses by a precipitation procedure: correlation with preparative and analytical ultracentrifugation. Report of the High Density Lipoprotein Methodology Workshop, K Lippel, BethesdaMaryland 1979; 328–40, DHEW NIH Publication No. 79–1661
   Google Scholar
• Svendsen P J., Weeke B, Johansson B G. Chemicals, solutions, equipment and general procedures. Handbook of Immunoprecipitation-in-Gel Techniques, N H. Axelsen, 1983; 3–20, Scand J Immunol;17 suppl 10
   Google Scholar
• Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 1968; 9: 570–9
   PubMed Web of Science ®Google Scholar
• Olegård R, Svennerholm L. Fatty acid composition of plasma and red cell phosphoglycerides in full term infants and their mothers. Acta Paediat Scand 1970; 59: 637–47
   PubMed Web of Science ®Google Scholar
• Bush I E. Methods of paper chromatography of steroids applicable to the study of steroids in mammalian blood and tissues. Biochem J 1952; 50: 370–8
   PubMed Web of Science ®Google Scholar
• Brenner P F., Guerrero R, Cekan Z, Diczfalusy E. Radioimmunoassay method for six steroids in human plasma. Steroids 1973; 22: 775–94
   PubMed Web of Science ®Google Scholar
• Heyns W, van Baelen H, de Moor P. Study of steroid-protein binding by means of competitive adsorption: application to cortisol binding in plasma. Clin Chim Acta 1967; 18: 361–70
   Google Scholar
• Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 31: 660–72
   Google Scholar
• Rosenthal H E. A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 1967; 20: 525–32
   PubMed Web of Science ®Google Scholar
• Zander J, Forbes T R., von Münstermann A M., Neher R. Δ4-3-ketopregnene-20α-01 and Ad-3-ketopregnene-20β-01, two naturally occuring metabolites of progesterone. Isolation, identification, biologic activity and concentration in human tissues. J Clin Endocrinol Metab 1958; 18: 337–53
   Google Scholar
• Lin T J., Billiar R B., Little B. Metabolic clearance rate of progesterone in the menstrual cycle. J Clin Endocrinol Metab 1972; 35: 879–86
   PubMed Web of Science ®Google Scholar
• Aedo A R., Pedersen P H., Pedersen S C., Diczfalusy E. Ovarian steroid secretion in normally menstruating women. II. The contribution of the corpus luteum. Acta Endocrinol (Copenh) 1981; 95: 222–31
   Google Scholar
• Landgren B-M, Campa S, Cekan S Z., Diczfalusy E. Studies on the pattern of circulating steroids in the normal menstrual cycle. 5. Changes around the onset of menstruation. Acta Endocrinol (Copenh) 1977; 86: 608–620
   Google Scholar
• Gambrell R D., Jr. The prevention of endometrial cancer in postmenopausal women with progestogens. Maturitas 1978; 1: 107–12
   PubMed Web of Science ®Google Scholar
• Studd J WW, Thom M H., Paterson M EL, Wade-Evans T. The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous oestrogens. The Menopause and Postmenopause, N Pasetto, R Paoletti, J L. Ambrus. MTP Press, Lancaster 1980; 127–39
   Google Scholar
• Whitehead M I., Townsend P T., Pryse-Davies J, Ryder T A., King R JB. Effect of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981; 305: 1599–1605
   PubMed Web of Science ®Google Scholar
• Whitehead M I., Townsend P T., Pryse-Davies J, et al. Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low dose estrogen therapy. Am J Obstet Gynecol 1982; 142: 791–5
   PubMed Web of Science ®Google Scholar
• Kincl F A., Ciaccio L A., Benagiano G. Increasing oral bioavailability of progesterone by formulation. J Steroid Biochem 1978; 9: 83–4
   Google Scholar
• Gurpide E, Holinka C. Pregnancy related changes in the metabolism of hormones. Maternal-fetal endocrinology, D Tulchinsky, K J. Ryan. WB Saunders, Philadelphia 1980; 45–57
   Google Scholar
• Neifeld J P., Lippman M E., Tormey D C. Steroid hormone receptors in normal human lymphocytes. J Biol Chem 1977; 252: 2972–7
   PubMed Web of Science ®Google Scholar
• Parker C R., Everett R B., Whalley P J., Quirk J G., Cant N F., MacDonald P C. Hormone production during pregnancy in the primigravid patient. II. Plasma levels of deoxycorticosterone throughout pregnancy of normal women and women who developed pregnancy-induced hypertension. Am J Obstet Gynecol 1980; 138: 626–31
   Google Scholar
• Parker C R., Winkel C A., Rush A J., Jr., Porter J C., MacDonald P C. Plasma concentrations of II-deoxycorticosterone in women during the menstrual cycle. Obstet Gynecol 1981; 58: 26–30
   PubMed Web of Science ®Google Scholar
• Antonipillai I, Moghissi E, Hawks D, Schneider T, Horton R. The origin of plasma deoxycorticosterone in men and in women during the menstrual cycle. J Clin Endocrinol Metab 1983; 56: 93–8
   PubMedGoogle Scholar
• Adlercreutz H, Martin F. Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 1980; 13: 231–44
   PubMedGoogle Scholar
• Landau R L., Lugibihl K. Inhibition of the sodium retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab 1958; 18: 1237–45
   PubMed Web of Science ®Google Scholar
• Sharp G WG, Komack C L., Leaf A. Studies on the binding of aldosterone in the toad bladder. J Clin Invest 1966; 45: 450–9
   Google Scholar
• Wambach G, Higgins J. Antimineralocorticoid action of progesterone in the rat: Correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors. Endocrinology 1980; 102: 1686–93
   Google Scholar
• L-Å Mattson, Silfverstolpe G, Samsioe G. Lipid composition of serum lipoproteins in relation to gonadal hormones during the normal menstrual cycle. Eur J Obstet Gynecol Reprod Biol, (in press)
   Google Scholar
• Nisker J A., Siiteri P K. Estrogens and breast cancer. Clin Obstet Gynecol 1981; 24: 301–23
   Google Scholar
• Ottosson U B., Damber J E., Damber M G., et al. Effects on sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinyloestradiol and norethisterone. Maturitas 1981; 3: 295–300
   Google Scholar
• Heller R F., Wheeler M J., Micallef J, Miller N E., Lewis B. Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone binding globulin. Acta Endocrinol (Copenh) 1983; 104: 253–6
   Google Scholar
• Bardin C W. The androgenic, antiandrogenic and synandrogenic actions of progestins. Progesterone and Progestins, C W. Bardin, E Milgröm, P. Mauvais-Jarvis. Raven Press, New York 1983; 135–47
   Google Scholar
• Crona N, Enk L, Samsioe G, Silfverstolpe G, Skryten A. High-dose depot-medroxyprogesterone acetate (DMPA)-effect on lipid and lipoprotein metabolism. Eur J Obstet Gynecol Reprod Biol 1983; 16: 97–105
   PubMed Web of Science ®Google Scholar
• Beckman L, von Schoultz B, Stigbrand T. “Pregnancy zone protein” in sera from patients with prostatic cancer treated with oestrogens. Urol Res 1973; 1: 67–9
   Google Scholar
• Wynn V, Niththyananthan R. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am J Obstet Gynecol 1981; 142: 766–72
   Google Scholar
• Whitehead M I., Townsend P T., Pryse-Davies J, et al. Effects of various types and dosages of progestogens on the postmenopausal endometrium. J Reprod Med 1982; 27: 539–48
   PubMed Web of Science ®Google Scholar
• Ylöjstalo P, Kauppila A, Kivinen S, Tuimala R, Vihko R. Endocrine and metabolic effects of low-dose estrogen-progestin treatment in climacteric women. Obstet Gynecol 1983; 62: 682–6
   Google Scholar
• Silfverstolpe G, Johnson P, Samsioe G, Svanborg A, Gustafson A. Lipid metabolic studies in oophorectomized women. Effects induced by the addition of norethisterone acetate to two different oestrogens on serum individual phospholipids and serum lecithin fatty acid composition. Acta Endocrinol (Copenh) 1981; 96: 527–33
   Google Scholar
• Ogburn P L., Johnson S B., Williams P P., Holman R T. Levels of free fatty acids and arachidonic acid in pregnancy and labor. J Lab Clin Med 1980; 95: 943–9
   Google Scholar
• Ogburn P L., Williams P P., Johnson S B., Holman R T. Serum arachidonic acid levels in normal and pre-eclamptic pregnancies. Am J Obstet Gynecol 1984; 1485–9
   Google Scholar
• Witter F R., DiBlasi M C. Effect of steroid hormones on arachidonic acid metabolites of endothelial cells. Obstet Gynecol 1984; 63: 747–51
   PubMed Web of Science ®Google Scholar